Report cover image

Avenanthramides Market Size, Share & Trends Analysis Report By Product (Natural, Synthetic), By End-use (Personal Care & Cosmetics, Pharmaceuticals, Animal Health), By Region (North America, Europe, Asia Pacific), And Segment Forecasts, 2025 - 2033

Publisher Grand View Research
Published Oct 09, 2025
Length 80 Pages
SKU # GV20575277

Description

Avenanthramides Market Summary

The global avenanthramides market size was estimated at USD 134.7 million in 2024 and is projected to reach USD 295.0 million by 2033, growing at a CAGR of 9.3% from 2025 to 2033. Demand is rising because the cosmetic, pharmaceutical, and nutraceutical sectors seek natural, evidence-backed anti-inflammatories; patents, clinical advances, and consumer preference for oat-derived actives amplify uptake, while limited raw material supply and complex extraction keep prices and margins elevated and encourage higher investment in specialized processing capacity.

Consumers favor natural, clinically validated actives; formulators value avenanthramides' dual antioxidant and anti-inflammatory profile; and pharmaceutical interest is rising as early clinical data support safety. Premiumization allows higher margins, prompting ingredient houses and biotech firms to invest in extraction, standardization, and stability research. Geographic demand concentrates in North America, Europe, and the Asia Pacific, where regulatory pathways and skincare markets are mature. Yet growth is constrained by limited oat-bran feedstock rich in avenanthramides, variable phytochemical yields across cultivars, and costly purification. Smaller suppliers face barriers to scaling GMP production, while larger players secure IP and long-term supply agreements to protect market share. Strategic R&D partnerships and contract manufacturing help de-risk supply and speed commercialization while investors back scale-up initiatives.

The rising preference for personalized beauty and nutrition solutions. Brands are reformulating products with bioactive compounds that address niche concerns such as sensitive skin, eczema, and lifestyle-related inflammation. Avenanthramides, being rare and scientifically validated, allow companies to differentiate offerings in a highly competitive environment.

Furthermore, sustainability is shaping demand. As oat cultivation is relatively low-impact compared to many other crops, avenanthramide sourcing aligns well with clean-label and eco-friendly initiatives. This sustainability narrative strengthens consumer trust, attracts premium pricing opportunities, and positions avenanthramides as an ingredient of choice in both advanced cosmeceuticals and functional health products.

Global Avenanthramides Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2033. For this study, Grand View Research has segmented the global avenanthramides market report based on product, end-use, and region:
  • Product Outlook (Revenue, USD Million; Volume, Kilotons; 2018 - 2033)
  • Natural
  • Synthetic
  • End-use Outlook (Revenue, USD Million; Volume, Kilotons; 2018 - 2033)
  • Personal Care & Cosmetics
  • Pharmaceuticals
  • Animal Health
  • Other End-use
  • Regional Outlook (Revenue, USD Million; Volume, Kilotons; 2018 - 2033)
  • North America
  • U.S.
  • Canada
  • Mexico
  • Latin America
  • Brazil
  • Argentina
  • Europe
  • Germany
  • UK
  • Italy
  • Spain
  • France
  • Asia Pacific
  • China
  • Japan
  • South Korea
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
Please note The report will be delivered in 4-8 business days upon order notification.

Table of Contents

80 Pages
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Market Definition
1.3. Information Procurement
1.3.1. Purchased Database
1.3.2. GVR’s Internal Database
1.3.3. Secondary Sources & Third-Party Perspectives
1.3.4. Primary Research
1.4. Information Analysis
1.4.1. Data Analysis Models
1.5. Market Formulation & Data Visualization
1.6. Data Validation & Publishing
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Avenanthramides Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Avenanthramides Market Outlook
3.2. Industry Value Chain Analysis
3.2.1. Raw Material Outlook
3.2.2. Manufacturing Trends
3.2.3. Sales Channel Analysis
3.3. Price Trend Analysis, 2018-2033
3.3.1. Factor Influencing Prince Trends
3.4. Regulatory Framework
3.5. Market Dynamics
3.5.1. Market Driver Analysis
3.5.2. Market Restraint Analysis
3.5.3. Industry Challenges
3.5.4. Industry Opportunities
3.6. Industry Analysis Tools
3.6.1. Porter’s Five Forces Analysis
3.6.2. Macro-Environmental Analysis
Chapter 4. Avenanthramides Market: Product Estimates & Trend Analysis
4.1. Product Movement Analysis & Market Share, 2023 & 2033
4.2. Natural
4.2.1. Natural Avenanthramides Market Estimates & Forecast, By Product, 2018 To 2033 (Kilotons) (USD Million)
4.3. Synthetic
4.3.1. Synthetic Avenanthramides Market Estimates & Forecast, By Product, 2018 To 2033 (Kilotons) (USD Million)
Chapter 5. Avenanthramides Market: End Use Estimates & Trend Analysis
5.1. Product Movement Analysis & Market Share, 2023 & 2033
5.2. Personal Care & Cosmetics
5.2.1. Personal Care & Cosmetics Avenanthramides Market Estimates & Forecast, By Product, 2018 To 2033 (Kilotons) (USD Million)
5.3. Pharmaceuticals
5.3.1. Pharmaceuticals Avenanthramides Market Estimates & Forecast, By Product, 2018 To 2033 (Kilotons) (USD Million)
5.4. Animal Health
5.4.1. Animal Health Avenanthramides Market Estimates & Forecast, By Product, 2018 To 2033 (Kilotons) (USD Million)
5.5. Other End Use
5.5.1. Other End Use Avenanthramides Market Estimates & Forecast, By Product, 2018 To 2033 (Kilotons) (USD Million)
Chapter 6. Avenanthramides Market: Regional Estimates & Trend Analysis
6.1. Regional Movement Analysis & Market Share, 2023 & 2033
6.2. North America
6.2.1. North America Avenanthramides Estimates & Forecast, By Product, 2018 - 2033 (Kilotons) (USD Million)
6.2.2. North America Avenanthramides Estimates & Forecast, By End Use, 2018 - 2033 (Kilotons) (USD Million)
6.2.3. U.S.
6.2.3.1. Key Country Dynamics
6.2.3.2. U.S. Avenanthramides Estimates & Forecast, By Product, 2018 - 2033 (Kilotons) (USD Million)
6.2.3.3. U.S. Avenanthramides Estimates & Forecast, By End Use, 2018 - 2033 (Kilotons) (USD Million)
6.2.4. Canada
6.2.4.1. Key Country Dynamics
6.2.4.2. Canada Avenanthramides Estimates & Forecast, By Product, 2018 - 2033 (Kilotons) (USD Million)
6.2.4.3. Canada Avenanthramides Estimates & Forecast, By End Use, 2018 - 2033 (Kilotons) (USD Million)
6.2.5. Mexico
6.2.5.1. Key Country Dynamics
6.2.5.2. Mexico Avenanthramides Estimates & Forecast, By Product, 2018 - 2033 (Kilotons) (USD Million)
6.2.5.3. Mexico Avenanthramides Estimates & Forecast, By End Use, 2018 - 2033 (Kilotons) (USD Million)
6.3. Europe
6.3.1. Europe Avenanthramides Estimates & Forecast, By Product, 2018 - 2033 (Kilotons) (USD Million)
6.3.2. Europe Avenanthramides Estimates & Forecast, By End Use, 2018 - 2033 (Kilotons) (USD Million)
6.3.3. Germany
6.3.3.1. Key Country Dynamics
6.3.3.2. Germany Avenanthramides Estimates & Forecast, By Product, 2018 - 2033 (Kilotons) (USD Million)
6.3.3.3. Germany Avenanthramides Estimates & Forecast, By End Use, 2018 - 2033 (Kilotons) (USD Million)
6.3.4. UK
6.3.4.1. Key Country Dynamics
6.3.4.2. UK Avenanthramides Estimates & Forecast, By Product, 2018 - 2033 (Kilotons) (USD Million)
6.3.4.3. UK Avenanthramides Estimates & Forecast, By End Use, 2018 - 2033 (Kilotons) (USD Million)
6.3.5. France
6.3.5.1. Key Country Dynamics
6.3.5.2. France Avenanthramides Estimates & Forecast, By Product, 2018 - 2033 (Kilotons) (USD Million)
6.3.5.3. France Avenanthramides Estimates & Forecast, By End Use, 2018 - 2033 (Kilotons) (USD Million)
6.3.6. Italy
6.3.6.1. Key Country Dynamics
6.3.6.2. Italy Avenanthramides Estimates & Forecast, By Product, 2018 - 2033 (Kilotons) (USD Million)
6.3.6.3. Italy Avenanthramides Estimates & Forecast, By End Use, 2018 - 2033 (Kilotons) (USD Million)
6.3.7. Spain
6.3.7.1. Key Country Dynamics
6.3.7.2. Spain Avenanthramides Estimates & Forecast, By Product, 2018 - 2033 (Kilotons) (USD Million)
6.3.7.3. Spain Avenanthramides Estimates & Forecast, By End Use, 2018 - 2033 (Kilotons) (USD Million)
6.4. Asia Pacific
6.4.1. Asia Pacific Avenanthramides Estimates & Forecast, By Product, 2018 - 2033 (Kilotons) (USD Million)
6.4.2. Asia Pacific Avenanthramides Estimates & Forecast, By End Use, 2018 - 2033 (Kilotons) (USD Million)
6.4.3. China
6.4.3.1. Key Country Dynamics
6.4.3.2. China Avenanthramides Estimates & Forecast, By Product, 2018 - 2033 (Kilotons) (USD Million)
6.4.3.3. China Avenanthramides Estimates & Forecast, By End Use, 2018 - 2033 (Kilotons) (USD Million)
6.4.4. India
6.4.4.1. Key Country Dynamics
6.4.4.2. India Avenanthramides Estimates & Forecast, By Product, 2018 - 2033 (Kilotons) (USD Million)
6.4.4.3. India Avenanthramides Estimates & Forecast, By End Use, 2018 - 2033 (Kilotons) (USD Million)
6.4.5. Japan
6.4.5.1. Key Country Dynamics
6.4.5.2. Japan Avenanthramides Estimates & Forecast, By Product, 2018 - 2033 (Kilotons) (USD Million)
6.4.5.3. Japan Avenanthramides Estimates & Forecast, By End Use, 2018 - 2033 (Kilotons) (USD Million)
6.4.6. South Korea
6.4.6.1. Key Country Dynamics
6.4.6.2. South Korea Avenanthramides Estimates & Forecast, By Product, 2018 - 2033 (Kilotons) (USD Million)
6.4.6.3. South Korea Avenanthramides Estimates & Forecast, By End Use, 2018 - 2033 (Kilotons) (USD Million)
6.5. Latin America
6.5.1. Latin America Avenanthramides Estimates & Forecast, By Product, 2018 - 2033 (Kilotons) (USD Million)
6.5.2. Latin America Avenanthramides Estimates & Forecast, By End Use, 2018 - 2033 (Kilotons) (USD Million)
6.5.3. Brazil
6.5.3.1. Key Country Dynamics
6.5.3.2. Brazil Avenanthramides Estimates & Forecast, By Product, 2018 - 2033 (Kilotons) (USD Million)
6.5.3.3. Brazil Avenanthramides Estimates & Forecast, By End Use, 2018 - 2033 (Kilotons) (USD Million)
6.5.4. Argentina
6.5.4.1. Key Country Dynamics
6.5.4.2. Argentina Avenanthramides Estimates & Forecast, By Product, 2018 - 2033 (Kilotons) (USD Million)
6.5.4.3. Argentina Avenanthramides Estimates & Forecast, By End Use, 2018 - 2033 (Kilotons) (USD Million)
6.6. Middle East & Africa
6.6.1. Middle East & Africa Avenanthramides Estimates & Forecast, By Product, 2018 - 2033 (Kilotons) (USD Million)
6.6.2. Middle East & Africa Avenanthramides Estimates & Forecast, By End Use, 2018 - 2033 (Kilotons) (USD Million)
6.6.3. Saudi Arabia
6.6.3.1. Key Country Dynamics
6.6.3.2. Saudi Arabia Avenanthramides Estimates & Forecast, By Product, 2018 - 2033 (Kilotons) (USD Million)
6.6.3.3. Saudi Arabia Avenanthramides Estimates & Forecast, By End Use, 2018 - 2033 (Kilotons) (USD Million)
6.6.4. South Africa
6.6.4.1. Key Country Dynamics
6.6.4.2. South Africa Avenanthramides Estimates & Forecast, By Product, 2018 - 2033 (Kilotons) (USD Million)
6.6.4.3. South Africa Avenanthramides Estimates & Forecast, By End Use, 2018 - 2033 (Kilotons) (USD Million)
Chapter 7. Avenanthramides Market - Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Company Categorization
7.3. Company Market Share/Position Analysis, 2024
7.4. Company Heat Map Analysis
7.5. Strategy Mapping
7.6. Company Profiles
7.6.1. Ceapro Inc.
7.6.1.1. Participant’s Overview
7.6.1.2. Financial Performance
7.6.1.3. Product Benchmarking
7.6.1.4. Recent Developments
7.6.2. Cosciens Biopharma Inc.
7.6.3. Chemicea Pharma
7.6.4. Symrise AG
7.6.5. Chen Lan gBio
7.6.6. Henan Steeda Industrial Co., Ltd.
7.6.7. BioCrick

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us